494
Views
19
CrossRef citations to date
0
Altmetric
Articles

Patterns of Use, Acute Subjective Experiences, and Motivations for Using Synthetic Cathinones (“Bath Salts”) in Recreational Users

, Ph.D., , M.A., , Ph.D., , Ph.D., , Ph.D., , Ph.D., , Ph.D., , Ph.D., , Ph.D., , M.A., , M.A., , M.A., , Ph.D., , Ph.D., , Ph.D., , B.A. & , M.A. show all
Pages 336-343 | Received 04 Mar 2016, Accepted 08 Aug 2016, Published online: 28 Sep 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Lauren Zimmerman, Tess M. Kilwein, Danielle Beyer, Cassidy Marks & Alison Looby. (2019) “Not for Human Consumption”: A Descriptive Investigation into User Characteristics, Motives, and Consequences Associated with Bath Salt Use. Journal of Psychoactive Drugs 51:3, pages 218-224.
Read now
Matej Sande, Mina Paš, Klara Nahtigal & Simona Šabić. (2018) Patterns of NPS Use and Risk Reduction in Slovenia. Substance Use & Misuse 53:9, pages 1424-1432.
Read now
Kirstin J. Lauritsen, Harold Rosenberg & Jon E. Sprague. (2018) University students’ attributions for abstinence from synthetic cannabinoids and synthetic cathinones. The American Journal of Drug and Alcohol Abuse 44:1, pages 64-72.
Read now

Articles from other publishers (16)

Shanshan Chen, Wenhua Zhou & Miaojun Lai. (2024) Synthetic Cathinones: Epidemiology, Toxicity, Potential for Abuse, and Current Public Health Perspective. Brain Sciences 14:4, pages 334.
Crossref
Gniewko Więckiewicz, Iga Florczyk, Maciej Stokłosa, Marta Jurga, Piotr Gorczyca & Magdalena Kotlicka-Antczak. (2024) Intensity of Psychoactive Substance Use Affects the Occurrence of Prodromal Symptoms of Psychosis. Journal of Clinical Medicine 13:3, pages 760.
Crossref
Ana Sofia Almeida, Bárbara Silva, Fernando Remião & Carla Fernandes. (2023) Assessment of the Permeability of 3,4-Methylenedioxypyrovalerone (MDPV) across the Caco-2 Monolayer for Estimation of Intestinal Absorption and Enantioselectivity. International Journal of Molecular Sciences 24:3, pages 2680.
Crossref
Malin Vedøy Uthaug, Alan K Davis, Trevor Forrest Haas, Dawn Davis, Sean B Dolan, Rafael Lancelotta, Christopher Timmermann & Johannes G Ramaekers. (2021) The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects. Journal of Psychopharmacology 36:3, pages 309-320.
Crossref
Sara Schiavi, Francesca Melancia, Emilia Carbone, Valeria Buzzelli, Antonia Manduca, Patricia Jiménez Peinado, Clemens Zwergel, Antonello Mai, Patrizia Campolongo, Louk J.M.J. Vanderschuren & Viviana Trezza. (2020) Detrimental effects of the ‘bath salt’ methylenedioxypyrovalerone on social play behavior in male rats. Neuropsychopharmacology 45:12, pages 2012-2019.
Crossref
Michael B. Gatch, Sean B. Dolan & Michael J. Forster. (2020) Methylenedioxymethamphetamine-like discriminative stimulus effects of seven cathinones in rats. Behavioural Pharmacology 31:4, pages 378-384.
Crossref
Yu Chen, Huyen T.N. Tran, Yasir H. Saber & F. Scott Hall. (2020) High ambient temperature increases the toxicity and lethality of 3,4-methylenedioxymethamphetamine and methcathinone. Pharmacology Biochemistry and Behavior 192, pages 172912.
Crossref
Dawn E. Muskiewicz, Federico Resendiz-Gutierrez, Omar Issa & F. Scott Hall. (2020) Synthetic psychoactive cathinones: hypothermia and reduced lethality compared to methamphetamine and methylenedioxymethamphetamine. Pharmacology Biochemistry and Behavior 191, pages 172871.
Crossref
Kirsten E. Smith & William W. Stoops. (2019) Synthetic Cathinone Use Among Polysubstance Users: Indirect Indicator of Indiscriminate Drug Taking or Preferred Drug of Abuse?. Journal of Drug Issues 49:2, pages 369-386.
Crossref
Steven J. Simmons, Jonna M. Leyrer-Jackson, Chicora F. Oliver, Callum Hicks, John W. Muschamp, Scott M. Rawls & M. Foster Olive. (2018) DARK Classics in Chemical Neuroscience: Cathinone-Derived Psychostimulants. ACS Chemical Neuroscience 9:10, pages 2379-2394.
Crossref
Alan K Davis, Joseph P Barsuglia, Rafael Lancelotta, Robert M Grant & Elise Renn. (2018) The epidemiology of 5-methoxy- N, N -dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption . Journal of Psychopharmacology 32:7, pages 779-792.
Crossref
Gholamreza Naseri, Alireza Fazel, Mohammad Jafar Golalipour, Hossein Haghir, Hamid Sadeghian, Majid Mojarrad, Mahmoud Hosseini, Shokouh Shahrokhi Sabzevar, Farimah Beheshti & Ahmad Ghorbani. (2018) Exposure to mephedrone during gestation increases the risk of stillbirth and induces hippocampal neurotoxicity in mice offspring. Neurotoxicology and Teratology 67, pages 10-17.
Crossref
Laurent Karila, Geneviève Lafaye, Amandine Scocard, Olivier Cottencin & Amine Benyamina. (2018) MDPV and α-PVP use in humans: The twisted sisters. Neuropharmacology 134, pages 65-72.
Crossref
John M. Corkery, Amira Guirguis, Duccio G. Papanti, Laura Orsolini & Fabrizio Schifano. 2018. Synthetic Cathinones. Synthetic Cathinones 153 189 .
Eric L. Harvey, Rachel L. Burroughs & Lisa E. Baker. (2017) Effects of D1 and D2 receptor antagonists on the discriminative stimulus effects of methylendioxypyrovalerone and mephedrone in male Sprague-Dawley rats trained to discriminate d-amphetamine. Behavioural Pharmacology 28:7, pages 586-589.
Crossref
Maria João Valente, Maria de Lourdes Bastos, Eduarda Fernandes, Félix Carvalho, Paula Guedes de Pinho & Márcia Carvalho. (2017) Neurotoxicity of β-Keto Amphetamines: Deathly Mechanisms Elicited by Methylone and MDPV in Human Dopaminergic SH-SY5Y Cells. ACS Chemical Neuroscience 8:4, pages 850-859.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.